Ticker Details
Organogenesis Holdings Inc.
IPO Date:	January 2, 2017
Sector:	Healthcare
Industry:	Drug Manufacturers - Specialty and Generic
Market Cap:	$506.38M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.30 | 3.58%
Avg Daily Range (30 D):	$0.09 | 2.34%
Avg Daily Range (90 D):	$0.13 | 2.69%

Institutional Daily Volume
Avg Daily Volume:	.63M
Avg Daily Volume (30 D):	.44M
Avg Daily Volume (90 D):	1.16M

Trade Size
Avg Trade Size (Sh.):	118
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	114

Institutional Trades
Total Institutional Trades:	911
Avg Institutional Trade:	$2.32M
Avg Institutional Trade (30 D):	$.88M
Avg Institutional Trade (90 D):	$2.18M
Avg Institutional Trade Volume:	.37M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.05M
Avg Closing Trade (30 D):	$.62M
Avg Closing Trade (90 D):	$.84M
Avg Closing Volume:	257.86K

News

Feb 3, 2026 @ 6:59 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Dec 30, 2025 @ 9:38 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Pomerantz Llp

Nov 20, 2025 @ 6:00 PM Global Wound Healing Devices Market Poised for Rob... Source: Delveinsight

Oct 17, 2025 @ 6:20 PM Organogenesis Holdings Inc. Investigated for Secur... Source: Business Wire

Sep 26, 2025 @ 3:24 PM Why Is Organogenesis Stock Trading Lower Friday? Source: Vandana Singh

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.11	$-.1
Diluted EPS		$.11	$-.1
Revenue		$150.86M	$101.01M
Gross Profit
Net Income / Loss		$21.57M	$-9.39M
Operating Income / Loss		$20.73M	$-12.58M
Cost of Revenue
Net Cash Flow		$-9.36M	$-36.8M
PE Ratio